Total Payments
$17,953
2024 Payments
$695.78
Companies
39
Transactions
355
Medicare Patients
16,952
Medicare Billing
$2.0M
Payment Breakdown by Category
Travel$9,252 (51.5%)
Food & Beverage$8,701 (48.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $9,252 | 28 | 51.5% |
| Food and Beverage | $8,701 | 327 | 48.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $7,089 | 44 | $0 (2023) |
| W. L. Gore & Associates, Inc. | $2,266 | 7 | $0 (2017) |
| Abbott Laboratories | $1,254 | 29 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $970.72 | 73 | $0 (2024) |
| Medtronic, Inc. | $864.52 | 8 | $0 (2023) |
| ABIOMED | $818.00 | 30 | $0 (2024) |
| Cardiovascular Systems Inc. | $813.78 | 6 | $0 (2018) |
| PFIZER INC. | $384.68 | 25 | $0 (2024) |
| Amgen Inc. | $370.22 | 13 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $257.73 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $695.78 | 34 | Novartis Pharmaceuticals Corporation ($208.33) |
| 2023 | $2,212 | 49 | Medtronic, Inc. ($864.52) |
| 2022 | $924.40 | 37 | Abbott Laboratories ($228.85) |
| 2021 | $979.93 | 38 | Shockwave Medical, Inc ($171.62) |
| 2020 | $273.34 | 16 | Amarin Pharma Inc. ($62.50) |
| 2019 | $1,946 | 45 | Boston Scientific Corporation ($1,115) |
| 2018 | $7,503 | 79 | BOSTON SCIENTIFIC CORPORATION ($5,754) |
| 2017 | $3,420 | 57 | W. L. Gore & Associates, Inc. ($2,266) |
All Payment Transactions
355 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Obesity | ||||||
| 10/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.36 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/16/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Heart Failure | ||||||
| 09/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.87 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $145.52 | General |
| Category: Coronary | ||||||
| 08/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $24.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/02/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.22 | General |
| Category: Cardiovascular | ||||||
| 07/31/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/21/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 56 | 5,112 | 6,832 | $5.0M | $746,337 |
| 2022 | 44 | 3,739 | 5,454 | $2.8M | $433,616 |
| 2021 | 48 | 4,451 | 11,017 | $2.3M | $483,843 |
| 2020 | 43 | 3,650 | 7,153 | $1.8M | $362,170 |
Total Patients
16,952
Total Services
30,456
Medicare Billing
$2.0M
Procedure Codes
221
All Medicare Procedures & Services
221 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 145 | 146 | $1.0M | $245,882 | 23.7% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 157 | 168 | $510,498 | $105,936 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 487 | 685 | $279,103 | $60,844 | 21.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 295 | 298 | $338,344 | $40,142 | 11.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 170 | 684 | $174,420 | $28,325 | 16.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 375 | 432 | $124,783 | $26,144 | 21.0% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 36 | 36 | $151,200 | $22,041 | 14.6% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 26 | 37 | $110,210 | $14,953 | 13.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 132 | 147 | $63,923 | $14,722 | 23.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 73 | 145 | $47,726 | $13,330 | 27.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 101 | 103 | $103,490 | $13,088 | 12.6% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 12 | 12 | $151,430 | $12,958 | 8.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 67 | 67 | $101,420 | $12,774 | 12.6% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 21 | 21 | $55,209 | $12,464 | 22.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 240 | 245 | $77,706 | $12,432 | 16.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 90 | 90 | $47,790 | $10,086 | 21.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 104 | 163 | $37,080 | $9,965 | 26.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 189 | 191 | $72,704 | $9,630 | 13.2% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 52 | 55 | $70,751 | $9,085 | 12.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 55 | 88 | $47,515 | $7,139 | 15.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 21 | 21 | $78,322 | $6,437 | 8.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 457 | 487 | $40,926 | $5,004 | 12.2% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 156 | 157 | $191,880 | $4,106 | 2.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 28 | $17,961 | $3,596 | 20.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 37 | 38 | $21,131 | $3,366 | 15.9% |
About Dr. Jake Lebeau, MD
Dr. Jake Lebeau, MD is a Cardiovascular Disease healthcare provider based in Lake Charles, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1174659668.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jake Lebeau, MD has received a total of $17,953 in payments from pharmaceutical and medical device companies, with $695.78 received in 2024. These payments were reported across 355 transactions from 39 companies. The most common payment nature is "Travel and Lodging" ($9,252).
As a Medicare-enrolled provider, Lebeau has provided services to 16,952 Medicare beneficiaries, totaling 30,456 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 221 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Hospitalist, Interventional Cardiology
- Location Lake Charles, LA
- Active Since 02/26/2007
- Last Updated 05/05/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1174659668
Products in Payments
- WATCHMAN (Device) $4,265
- EXCLUDER Iliac Branch Endoprosthesis (Device) $2,263
- STINGRAY (Device) $1,491
- GENERAL VASCULAR ACCESS (Device) $1,133
- MICRA (Device) $864.52
- Impella (Device) $818.00
- Peripheral Orbital Atherectomy System (Device) $813.78
- ENTRESTO (Drug) $777.01
- ELIQUIS (Drug) $473.31
- Repatha (Biological) $320.57
- CardioMEMS HF System (Device) $313.98
- AMPLATZER AMULET (Device) $241.88
- FFRct (Device) $239.24
- CARDIOMEMS (Device) $227.41
- XARELTO (Drug) $214.46
- LifeVest (Device) $194.67
- LEQVIO (Drug) $193.71
- Vascular Lithotripsy (Device) $171.62
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $167.11
- JARDIANCE (Drug) $166.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lake Charles
Dr. Corey Foster, Md, MD
Cardiovascular Disease — Payments: $254,379
Cardiovascular Disease $254,379
Richard Gilmore, Md, MD
Cardiovascular Disease — Payments: $62,090
Cardiovascular Disease $62,090
Dr. John Winterton, M.d, M.D
Cardiovascular Disease — Payments: $56,433
Cardiovascular Disease $56,433
Dr. Kevin Young, Md, MD
Cardiovascular Disease — Payments: $36,488
Cardiovascular Disease $36,488
Dr. Carriel Nipp, M.d, M.D
Cardiovascular Disease — Payments: $13,623
Cardiovascular Disease $13,623
Dr. Jean White, Md, MD
Cardiovascular Disease — Payments: $6,399
Cardiovascular Disease $6,399